CBC NEWS

World U.S. gov't releases 'playbook' for free COVID-19 vaccines for Americans

1 in 5 Americans say they will not get a coronavirus vaccine shot The Associated Press Posted: 3 Hours Ago 89747046 The U.S. federal government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans. (David Greedy/Getty Images) Read Comments The U.S. government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans, even as polls show a strong undercurrent of skepticism rippling across the land. In a report to Congress and an accompanying "playbook" for states and localities, federal health agencies and the Defence Department sketched out complex plans for a vaccination campaign to begin gradually in January or possibly later this year, eventually ramping up to reach any American who wants a shot. The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones giving shots. The campaign is "much larger in scope and complexity than seasonal influenza or other previous outbreak-related vaccination responses," said the playbook for states released by the Centers for Disease Control and Prevention. ADV

Among the highlights: For most vaccines, people will need two doses, 21 to 28 days apart. Double-dose vaccines will have to come from the same drug maker. There could be several vaccines from different manufacturers approved and available. Vaccination of the U.S. population won't be a sprint but a marathon. Initially, there may be a limited supply of vaccines available, and the focus will be on protecting health workers, other essential employees, and people in vulnerable groups. CDC's Advisory Committee on Immunization Practices, the National Academy of Medicine, and other organizations are working on priorities for the first phase. A second and third phase would expand vaccination to the entire country. The vaccine itself will be free of charge, and patients won't be charged out of pocket for the administration of shots, thanks to billions of dollars in taxpayer funding approved by Congress and allocated by the Trump administration. States and local communities will need to devise precise plans for receiving and locally distributing vaccines, some of which will require special handling such as refrigeration or freezing. States and cities have a month to submit plans. Researchers look at a sample of a respiratory virus at Novavax labs in Gaithersburg, Md. There is widespread concern that potential coronavirus vaccines are being rushed. (Abdrew Caballero-Reynolds/AFP/Getty Images)

Skepticism over rushed vaccine Some of the broad components of the federal plan have already been discussed, but Wednesday's reports attempt to put the key details into a comprehensive framework. Distribution is happening under the umbrella of Operation Warp Speed, a White House-backed initiative to have millions of doses ready to ship once a vaccine is given what's expected to be an emergency use approval by the Food and Drug Administration. Several formulations are undergoing final trials. But the whole enterprise is facing public skepticism. Only about half of Americans said they'd get vaccinated in an Associated Press poll taken in May. Of those who wouldn't get vaccinated, the overwhelming majority said they were worried about safety. To effectively protect the United States from the coronavirus, experts say upwards of 70 per cent of Americans must either be vaccinated or have their own immunity from fighting off COVID-19. A closer look at the vaccines Canada is betting on to stem the spread of COVID-19 SECOND OPINION What the level of COVID-19 immunity in Canada could mean for the vaccine hunt Since the poll, questions have only mounted about whether the government is trying to rush COVID-19 treatments and vaccines to help U.S. President Donald Trump's re-election chances.  Before the Republican National Convention in August, the FDA granted authorization for treatment of COVID-19 patients with plasma from people who have recovered, even though some government scientists were not convinced the clinical evidence was strong enough. And last week it was reported that Michael Caputo, a Health and Human Services Department political appointee, tried to gain editorial control over a weekly scientific publication from the CDC. U.S. President Donald Trump is hoping a COVID-19 vaccine will increase his re-election chances in the upcoming presidential race. (Mandel Ngan/AFP/Getty Images) As public confidence in core health agencies has taken a beating, Trump administration officials have been forced to play defence. "We are working closely with our state and local public health partners … to ensure that Americans can receive the vaccine as soon as possible and vaccinate with confidence," HHS Secretary Alex Azar said in a statement Wednesday. "Americans should know that the vaccine development process is being driven completely by science and the data." No cause for alarm after pause in COVID-19 trial, says co-chair of Canada's Vaccine Task Force That could be a tough sell. In the AP poll, one in five Americans said they would not get a coronavirus vaccine; 31 per cent said they were unsure. CBC's Journalistic Standards and Practices Report Typo or Error

RELATED STORIES Here's the outlook for COVID-19 vaccines after one late-stage trial was suspended this week Trudeau urges world leaders to pull together as U.S. steers clear of COVID-19 vaccine pledging conference U.S. narrows down candidates in major push for COVID-19 vaccine Your daily guide to the coronavirus outbreak. Get the latest news, tips on prevention and your coronavirus questions answered every evening. Email address: Current Time Ignore this field. If any data is entered for this field, you will not be subscribed to this newsletter. woman files human rights complaint for dress-code discrimination at car dealership 3147 reading now Ontario reports 315 new COVID-19 cases, will lower limits on gatherings in some regions 1188 reading now 23 new cases of COVID-19 in Manitoba, as tally rises again at John Pritchard school 1009 reading now It's easy to point the finger at parties — but younger Canadians spread COVID-19 in all kinds of settings 704 reading now Toronto murder victim dodged earlier assassin's bullet with cocaine bribe COMMENTS To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted. By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time. Leave a comment DISCOVER MORE FROM CBC LISTEN 'More than just a blip': Canada's COVID-19 cases on the rise Radio - Front Burner UPDATED Ontario reports 315 new COVID-19 cases, will lower limits on gatherings in some regions News - Canada - Toronto Toronto murder victim dodged earlier assassin's bullet with cocaine bribe News - Canada - Toronto Lawsuit alleges NHL, junior leagues conspiring to limit players' opportunities Sports - Hockey - NHL I'm a gay millennial and I want to be a father — but I can't Parents Pressure mounts on Health Canada to approve rapid COVID testing devices John Paul Tasker News - Politics Fall is the best time to tackle these 6 home improvement projects Life ©2020 CBC/Radio-Canada. All rights reserved

Coronavirus: Latest updates

Paul-Ehrlich-Institut: Corona vaccinations from the end of the year  +++ Here you find the most important news about the spread of the lung disease in Germany.

10.08.2020

Ngày 10 tháng 8 năm 2020: Viện Paul Ehrlich: Tiêm chủng Corona từ cuối năm
Berlin (dpa) - Viện Paul Ehrlich (PEI), cơ quan chịu trách nhiệm phê duyệt vắc xin ở Đức, vẫn tự tin trong việc tìm kiếm vắc xin corona. Chủ tịch PEI Klaus Cichutek nói với Redaktionsnetzwerk Deutschland (RND): “Tôi hiện giả định rằng các phê duyệt sẽ được cấp vào cuối năm 2020 và đầu năm sau, với điều kiện là dữ liệu thử nghiệm Giai đoạn III là tích cực”. Cái gọi là thử nghiệm Giai đoạn III được sử dụng để kiểm tra xem một loại vắc-xin có thực sự bảo vệ khỏi lây nhiễm hay không.

dpa

AUGUST 10TH, 2020:

August 10th, 2020: Paul-Ehrlich-Institut: Corona vaccinations from the end of the year

Berlin (dpa) - The Paul-Ehrlich-Institute (PEI), which is responsible for the approval of vaccines in Germany, remains confident in the search for a corona vaccine. "I currently assume that approvals will be granted at the end of 2020 and beginning of next year, provided that the Phase III trial data are positive," said PEI President Klaus Cichutek to Redaktionsnetzwerk Deutschland (RND). So-called Phase III trials are used to test whether a vaccine actually protects against infection.

+++

Corona-Impfung: Hoffnungsvolle Nachrichten! Impfstoff schneller als gedacht?

wunderweib

vor 13 Std.

Aldi-Süd ruft Cashew-Kerne zurück

Dr. Dre: Noch-Ehefrau will Ehevertrag anfechten

© Bereitgestellt von WUNDERWEIB Forscher überall auf der Welt arbeiten fieberhaft an einem Corona-Impfstoff. Wann wird es einen Corona-Impfstoff geben? Experten wagen jetzt eine Prognose, die Hoffnung macht.

Die Corona-Infektionszahlen steigen seit einigen Wochen wieder an und immer wieder kommt es zu lokalen Massenausbrüchen in Deutschland. Viele befürchten deshalb, dass es zu einer zweiten Corona-Welle kommt. Umso größer sind die Hoffnungen, dass es bald einen Impfstoff gegen das Virus geben wird.

Weltweite Forschung: Derzeit rund 150 Coronaimpfstoff-Projekte

Jetzt hat sich der Präsident des Paul-Ehrlich-Instituts Klaus Cichutek zu den Entwicklungen um einen Impfstoff geäußert und sich optimistisch gezeigt, dass in naher Zukunft Impfungen gegen das Coronavirus möglich sein werden. "Die Zuversicht ist groß, denn wir haben gerade in den letzten Wochen erlebt, dass wir aus den ersten klinischen Prüfungen Ergebnisse erhalten haben, die zeigen, dass einige Impfstoffe tatsächlich eine spezifische Immunreaktion beim Menschen gegen Coronavirus 2 induzieren können“, so der Experte im ZDF-"heute-journal".

Weltweite Corona-Impfung: Dieses Datum gibt neue Hoffnung

Das Paul-Ehrlich-Institut kümmert sich um die Genehmigung der klinischen Prüfungen und der Zulassung von Arzneimitteln. Cichutek zufolge gibt es derzeit rund 150 Impfstoff-Projekte, von denen sich 20 in der klinischen Prüfung befinden. 6 sind sogar bereits in Phase 2 bis 3. In der dritten Phase wird getestet, ob ein entwickelter Impfstoff tatsächlich vor einer Infektion schützt.

Klaus Cichutek glaubt an Impfstoff im ersten Quartal 2021

Doch wann könnte ein Impfstoff freigegeben werden? In dieser Hinsicht wagt Klaus Cichutek eine erste Prognose: "Es ist denkbar, das erste Firmen im Herbst Zulassungsanträge stellen und einzelne Produkte noch Ende 2020 zugelassen werden können. Mehrere Impfstoffprodukte könnten dann im ersten Quartal 2021 das Potential haben, zur Verfügung zu stehen“, erklärt der Chemiker im Interview mit RTL.

Vor wenigen Wochen erst vermeldeten britische Forscher erste Erfolge bei der Entwicklung eines Impfstoffs. An der Universität Oxford wird derzeit an einem Impfstoff gearbeitet, der bei den Probanden eine gute Immunantwort hatte, so die Wissenschaftler. Jetzt wird das Mittel in Phase 3 an tausenden Freiwilligen getestet.

http://rfi.my/6HwV

"...đã có 30 bệnh nhân và người nhà bỏ trốn khỏi bệnh viện Đà Nẵng - nơi chữa trị hai ca bệnh 416 và 418 đang rất nặng phải thở máy. Đặc biệt, theo quyền bộ trưởng Y Tế Nguyễn Thanh Long, virus xuất hiện ở Đà Nẵng là chủng mới, có thể từ nước ngoài, có đặc tính lây lan nhanh hơn. Bộ Y Tế đã đưa mẫu lên ngân hàng gien thế giới để so sánh.

Trước dư luận đang xôn xao vì một số tài khoản trong những nhóm kín trên mạng xã hội quảng cáo dịch vụ đưa người qua biên giới tránh cách ly, giám đốc công an Đà Nẵng hôm nay cho biết đã khởi tố và bắt tạm giam ba người, gồm một người Trung Quốc và hai người Việt. Vụ này sẽ sớm đưa ra xét xử vì tội « tổ chức nhập cảnh trái phép » để làm gương. Đến hôm nay Đà Nẵng đã phát hiện 60 người nhập cảnh trái phép, hầu hết là người Trung Quốc."